查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828114

2025年全球电子药物传输系统市场报告

Electronic Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，电子药物输送系统市场规模强劲成长，从2024年的111.5亿美元增加至2025年的119.3亿美元，复合年增长率为7.0%。预测期内的成长归因于慢性病盛行率上升、人口老化、患者对非侵入性治疗的偏好、医疗成本控制、临床进展以及检验。

预计未来几年电子药物输送系统市场规模将快速成长，到2029年将达到175.5亿美元，复合年增长率为10.1%。预测期内的成长可归因于药物个人化程度的提高、全球医疗支出的增加、以患者为中心的医疗保健方法、标靶治疗的兴起、支持性法规环境以及远端患者监护的进步。预测期内的主要趋势包括人工智慧 (AI)、生物相容性材料和植入式设备的整合、特定治疗领域的客製化、监管发展和标准化，以及製药公司和科技公司之间的合作。

电子药物输送系统涵盖旨在将药物精准输送至特定部位，同时避免非目标细胞和组织的装置和配方。这些系统可确保药物的可控给药，并方便监测剂量。

电子药物输送系统的主要类别包括电子输液帮浦、电子注射笔、电子自动注射器、电子吸入器、电子胶囊等。电子输液帮浦是控制液体输注到病人体内的医疗设备。这些帮浦部署在医院和疗养院等医疗环境中，帮助输送营养物质和药物等液体。电子药物传输系统的关键组件包括感测器、无线通讯、天线、微型帮浦、流量调节器、药物储存器和微控制器，有电池供电和充电两种版本。这些电子药物传输系统可治疗多种疾病，包括糖尿病、心血管疾病、呼吸系统疾病和多发性硬化症，并透过医院药局、零售药局和线上药局销售。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供电子药物输送系统（EDM）市场统计数据，例如全球电子药物输送系统（EDM）行业规模、各地区市场份额、竞争对手的市场份额、详细的电子药物输送系统（EDM）市场细分、市场趋势和机会，以及您在电子药物输送系统（EDM）行业取得成功所需的数据。本电子药物输送系统市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面的观点。

未来五年预测成长率为10.1%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自爱尔兰和新加坡等主要地区的智慧注射装置和剂量追踪微晶片征收关税直接影响美国，从而导致精准用药管理水平下降，并推高连网药物输送设备的成本。

预计电子药物输送系统市场的成长将受到慢性病盛行率上升的推动。慢性病病程通常超过一年，需要持续治疗，而电子药物传递系统可以帮助调整和监测药物剂量，从而为这类疾病提供治疗方案。例如，美国国家医学图书馆于2023年1月报告称，预计到2050年，美国50岁及以上患有至少一种慢性病的人数将达到1.4266亿。慢性病盛行率的上升趋势预计将刺激对电子药物传递系统的需求。

预计电子药物输送系统市场的成长也将受到医疗设施投资增加的推动。医疗设施投资是指用于购买、开发、升级和维护医疗服务所需的基础设施、设备、技术和其他资源的资金投入。电子药物输送系统的投资可以提供宝贵的药物管理数据，并实现即时监控和分析。这使得医疗服务提供者能够根据患者的反应做出明智的决策、识别趋势并优化治疗方案。例如，根据《莫斯科时报》报道，俄罗斯联邦初级医疗保健现代化计划在2023年拨款888亿卢布（9.1亿美元），并在2023年至2025年期间拨款5,500亿卢布（57亿美元）。因此，医疗设施投资的增加是电子药物输送系统市场成长的主要驱动力。

电子药物传输系统市场的一个突出趋势是技术先进、微创的药物传输系统的发展。为了保持竞争力，电子药物传输市场的主要企业正在推出创新且技术先进的药物输送系统。例如，2022年3月，德国特种化学品製造商赢创工业股份公司推出了EUDRATEC SoluFlow，这是一项旨在提高口服药物中活性药物成分溶解度的新型微粒技术。该技术是该公司口服药物传输产品组合的一部分，旨在治疗癌症、心血管疾病、感染疾病和糖尿病等疾病。

领先的公司正在与电子药物输送系统市场的新兴企业和中型公司建立策略合作伙伴关係，以扩展其产品和服务范围。策略伙伴关係关係是指两个或多个组织之间的协作，以实现特定的业务目标。例如，2022年10月，专门为製药、生物技术和非专利产业开发和製造药物输送设备解决方案的法国公司Nemera宣布与Zollner Elektronik AG建立合作伙伴关係。透过此次策略合作，Nemera和Zollner将结合各自在药物传输设备和製药行业的专业知识以及在医疗行业电子开发和製造方面的知识，从而增强两家公司的能力。 Zollner Elektronik AG是一家总部位于德国的电子药物传输系统服务提供者。

2022年3月，总部位于瑞士的製药公司山德士完成了对Coalesce Product Development Limited的收购，具体金额未披露。此次收购将使山德士获得Coalesce的研发能力，增强其现有的呼吸系统疾病治疗和高品质复合疗法产品组合。 Coalesce Product Development Limited是一家总部位于英国的医疗药物输送设备开发商。

电子药物传输系统市场的主要企业包括 Gerresheimer AG、Medtronic plc、Novo Nordisk A/S、Insulet Corporation、Bayer AG、Tandem Diabetes Care、United Therapeutics Corporation、F. Hoffmann-La Roche AG、Elcamat Medical Services、Sanofi SA、Cane SpA、Findd、Johnson 和Ltd.、H& T Presspart Manufacturing Ltd.、HCmed Innovations Co.Ltd.、Amiko Digital Health Limited、CeQur Corporation、West Pharmaceutical Services Inc. 和 BIOCORP。

2024年，北美是电子药物传输系统市场最大的地区。预计亚太地区将成为预测期内全球电子药物传输系统市场成长最快的地区。电子药物输送系统市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

电子药物输送系统市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

电子药物传输系统市场涵盖滴鼻剂、眼药水和避孕器的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球电子药物传输系统：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球电子药物传输系统市场：成长率分析
  • 全球电子药物传输系统市场表现：规模与成长，2019-2024
  • 全球电子药物传输系统市场预测：规模与成长，2024-2029年，2034年
  • 全球电子药物传输系统：总目标市场（TAM）

第六章 市场细分

  • 全球电子药物输送系统市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 电子输液帮浦
  • 电子注射笔
  • 电子自动注射器
  • 电子吸入器
  • 电子胶囊
  • 其他的
  • 全球电子药物传输系统市场（按组件、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 感应器
  • 通讯和天线
  • 微型帮浦和流量调节器
  • 药物储存器
  • 微控制器
  • 其他的
  • 全球电子药物输送系统市场（按系统类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 电池供电系统
  • 可充电系统
  • 全球电子药物输送系统市场（按分销管道）：实际结果与预测（2019-2024 年、2024-2029 年、2034 年）
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的
  • 全球电子药物输送系统市场的应用、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 糖尿病
  • 心血管疾病
  • 呼吸系统疾病
  • 多发性硬化症
  • 其他的
  • 全球电子药物输送系统市场：电子输液帮浦细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 容积式输液泵
  • 注射输液帮浦
  • 携带式输液泵
  • 全球电子药物输送系统市场：电子注射笔细分、类型、效能及预测（2019-2024、2024-2029、2034）
  • 胰岛素笔
  • 生长激素笔
  • 其他的
  • 全球电子药物输送系统市场：电子自动注射器细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 预填充自动注射器
  • 弹簧式自动注射器
  • 全球电子药物输送系统市场：电子吸入器细分市场、类型、性能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 定量喷雾吸入器（MDI）
  • 干粉吸入器（DPI）
  • 缓雾吸入器
  • 全球电子药物输送系统市场：电子胶囊细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 智慧胶囊
  • 带感测器的数位胶囊
  • 全球电子药物输送系统市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 经皮给药系统
  • 植入式药物传输系统
  • 穿戴式药物输送系统

第七章 区域和国家分析

  • 全球电子药物输送系统市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球电子药物输送系统市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 电子药物输送系统市场：竞争格局
  • 电子药物输送系统市场：公司简介
    • Gerresheimer AG
    • Medtronic plc
    • Novo Nordisk A/S
    • Insulet Corporation
    • Bayer AG

第31章：其他领先和创新企业

  • Tandem Diabetes Care
  • United Therapeutics Corporation
  • F. Hoffmann-La Roche AG
  • Elcam Medical
  • Sanofi SA
  • Cane SpA
  • FindAir
  • Johnson & Johnson Services Inc.
  • Antares Pharma Inc
  • Abbott Laboratories
  • Adherium Ltd.
  • H& T Presspart Manufacturing Ltd.
  • HCmed Innovations Co. Ltd.
  • Amiko Digital Health Limited
  • CeQur Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年电子药物输送系统市场：提供新机会的国家
  • 2029年电子药物传输系统市场：细分领域带来新机会
  • 2029年电子药物传输系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24104u

Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.

The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The electronic drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with an electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $11.15 billion in 2024 to $11.93 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising chronic diseases incidence, aging population, patient preference for non-invasive delivery, healthcare cost containment, clinical advancements, and validation.

The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $17.55 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing drug personalization, rising global healthcare expenditure, patient-centric healthcare approach, emergence of targeted therapies, supportive regulatory environment, and advancements in remote patient monitoring. Major trends in the forecast period include the incorporation of artificial intelligence (AI), biocompatible materials and implantable devices, customization for specific therapeutic areas, regulatory advancements and standardization, and collaborations between pharma and tech companies.

The forecast of 10.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on smart injection mechanisms and dose-tracking microchips, sourced from key regions such as Ireland and Singapore, which could lead to reduced precision medication administration and higher costs for connected drug delivery devices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.

The growth of the electronic drug delivery systems market is also anticipated to be propelled by the increasing investment in healthcare facilities. Investment in healthcare facilities involves financial commitments for acquiring, developing, upgrading, or maintaining infrastructure, equipment, technology, and other resources essential for healthcare service provision. Investments in electronic drug delivery systems contribute valuable data on medication administration, enabling real-time monitoring and analytics. This empowers healthcare providers to make informed decisions, identify trends, and optimize treatment plans based on patient responses. For instance, as reported by The Moscow Times, Russia's federal project on modernizing primary healthcare plans to allocate 88.8 billion rubles ($910 million) in 2023 and 550 billion rubles ($5.7 billion) for 2023-25. Consequently, the increasing investment in healthcare facilities is a significant driver of the electronic drug delivery systems market's growth.

A prominent trend in the electronic drug delivery system market is the development of technologically advanced and minimally invasive drug delivery systems. Leading companies in the electronic drug delivery market are introducing innovative and technologically sophisticated drug delivery systems to maintain their competitive positions. For example, in March 2022, Evonik Industries AG, a Germany-based specialty chemicals company, unveiled EUDRATEC SoluFlow, a novel microparticle technology designed to enhance the solubility of active pharmaceutical ingredients in oral drug products. This technology, part of the company's oral drug delivery portfolio, is aimed at addressing diseases such as cancer, cardiovascular diseases, infectious diseases, and diabetes.

Major companies are strategically forming partnerships and collaborations with startups and mid-sized companies in the electronic drug delivery system market to expand their product and service offerings. Strategic partnerships involve collaborative relationships between two or more organizations to achieve specific business objectives or goals. For instance, in October 2022, Nemera, a France-based company specializing in the development and manufacturing of drug delivery device solutions for the pharmaceutical, biotechnology, and generic industries, announced a partnership with Zollner Elektronik AG. This strategic alliance enhances both Nemera and Zollner's capabilities, combining expertise in drug delivery devices and the pharmaceutical industry with electronics development and manufacturing knowledge in the medical industry. Zollner Elektronik AG is a Germany-based provider of Electronic Drug Delivery Systems services.

In March 2022, Sandoz, a Switzerland-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed amount. This acquisition equips Sandoz with Coalesce's capabilities, enhancing the company's existing portfolio of respiratory medicines and high-quality, complex therapies. Coalesce Product Development Limited is a UK-based medical and drug delivery device development company.

Major companies operating in the electronic drug delivery systems market include Gerresheimer AG, Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Bayer AG, Tandem Diabetes Care, United Therapeutics Corporation, F. Hoffmann-La Roche AG, Elcam Medical, Sanofi S.A., Cane SpA, FindAir, Johnson & Johnson Services Inc., Antares Pharma Inc, Abbott Laboratories, Adherium Ltd., H&T Presspart Manufacturing Ltd., HCmed Innovations Co. Ltd., Amiko Digital Health Limited, CeQur Corporation, West Pharmaceutical Services Inc., BIOCORP

North America was the largest region in the electronic drug delivery systems market in 2024. Asia-pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electronic drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electronic drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Electronic Infusion Pumps; Electronic Injection Pens; Electronic Auto-Injectors; Electronic Inhalers; Electronic Capsules; Other Types
  • 2) By Component: Sensors; Wireless Communicator And Antennas; Micro Pumps And Flow Regulators; Drug Reservoir; Microcontroller; Other Components
  • 3) By System Type: Battery-Powered Systems; Rechargeable Systems
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By Application: Diabetes; Cardiovascular Disease; Respiratory Disorders; Multiple Sclerosis; Other Applications
  • Subsegments:
  • 1) By Electronic Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps
  • 2) By Electronic Injection Pens: Insulin Pens; Growth Hormone Pens; Other Injectable Medication Pens
  • 3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors; Spring-Loaded Auto-Injectors
  • 4) By Electronic Inhalers: Metered Dose Inhalers (MDI); Dry Powder Inhalers (DPI); Soft Mist Inhalers
  • 5) By Electronic Capsules: Smart Capsules; Digital Capsules With Sensors
  • 6) By Other Types: Transdermal Drug Delivery Systems; Implantable Drug Delivery Systems; Wearable Drug Delivery Systems
  • Companies Mentioned: Gerresheimer AG; Medtronic plc; Novo Nordisk A/S; Insulet Corporation; Bayer AG; Tandem Diabetes Care; United Therapeutics Corporation; F. Hoffmann-La Roche AG; Elcam Medical; Sanofi S.A.; Cane SpA; FindAir; Johnson & Johnson Services Inc.; Antares Pharma Inc; Abbott Laboratories; Adherium Ltd.; H&T Presspart Manufacturing Ltd.; HCmed Innovations Co. Ltd.; Amiko Digital Health Limited; CeQur Corporation; West Pharmaceutical Services Inc.; BIOCORP
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Electronic Drug Delivery Systems Market Characteristics

3. Electronic Drug Delivery Systems Market Trends And Strategies

4. Electronic Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Electronic Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Electronic Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Electronic Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Electronic Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Electronic Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Electronic Drug Delivery Systems Total Addressable Market (TAM)

6. Electronic Drug Delivery Systems Market Segmentation

  • 6.1. Global Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Infusion Pumps
  • Electronic Injection Pens
  • Electronic Auto-Injectors
  • Electronic Inhalers
  • Electronic Capsules
  • Other Types
  • 6.2. Global Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sensors
  • Wireless Communicator And Antennas
  • Micro Pumps And Flow Regulators
  • Drug Reservoir
  • Microcontroller
  • Other Components
  • 6.3. Global Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Battery-Powered Systems
  • Rechargeable Systems
  • 6.4. Global Electronic Drug Delivery Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.5. Global Electronic Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes
  • Cardiovascular Disease
  • Respiratory Disorders
  • Multiple Sclerosis
  • Other Applications
  • 6.6. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • 6.7. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Injection Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pens
  • Growth Hormone Pens
  • Other Injectable Medication Pens
  • 6.8. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Auto-Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-filled Auto-Injectors
  • Spring-Loaded Auto-Injectors
  • 6.9. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered Dose Inhalers (MDI)
  • Dry Powder Inhalers (DPI)
  • Soft Mist Inhalers
  • 6.10. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smart Capsules
  • Digital Capsules With Sensors
  • 6.11. Global Electronic Drug Delivery Systems Market, Segmentation By Other Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transdermal Drug Delivery Systems
  • Implantable Drug Delivery Systems
  • Wearable Drug Delivery Systems

7. Electronic Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Electronic Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Electronic Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Electronic Drug Delivery Systems Market

  • 8.1. Asia-Pacific Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Electronic Drug Delivery Systems Market

  • 9.1. China Electronic Drug Delivery Systems Market Overview
  • 9.2. China Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Electronic Drug Delivery Systems Market

  • 10.1. India Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Electronic Drug Delivery Systems Market

  • 11.1. Japan Electronic Drug Delivery Systems Market Overview
  • 11.2. Japan Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Electronic Drug Delivery Systems Market

  • 12.1. Australia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Electronic Drug Delivery Systems Market

  • 13.1. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Electronic Drug Delivery Systems Market

  • 14.1. South Korea Electronic Drug Delivery Systems Market Overview
  • 14.2. South Korea Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Electronic Drug Delivery Systems Market

  • 15.1. Western Europe Electronic Drug Delivery Systems Market Overview
  • 15.2. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Electronic Drug Delivery Systems Market

  • 16.1. UK Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Electronic Drug Delivery Systems Market

  • 17.1. Germany Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Electronic Drug Delivery Systems Market

  • 18.1. France Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Electronic Drug Delivery Systems Market

  • 19.1. Italy Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Electronic Drug Delivery Systems Market

  • 20.1. Spain Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Electronic Drug Delivery Systems Market

  • 21.1. Eastern Europe Electronic Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Electronic Drug Delivery Systems Market

  • 22.1. Russia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Electronic Drug Delivery Systems Market

  • 23.1. North America Electronic Drug Delivery Systems Market Overview
  • 23.2. North America Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Electronic Drug Delivery Systems Market

  • 24.1. USA Electronic Drug Delivery Systems Market Overview
  • 24.2. USA Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Electronic Drug Delivery Systems Market

  • 25.1. Canada Electronic Drug Delivery Systems Market Overview
  • 25.2. Canada Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Electronic Drug Delivery Systems Market

  • 26.1. South America Electronic Drug Delivery Systems Market Overview
  • 26.2. South America Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Electronic Drug Delivery Systems Market

  • 27.1. Brazil Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Electronic Drug Delivery Systems Market

  • 28.1. Middle East Electronic Drug Delivery Systems Market Overview
  • 28.2. Middle East Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Electronic Drug Delivery Systems Market

  • 29.1. Africa Electronic Drug Delivery Systems Market Overview
  • 29.2. Africa Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Electronic Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Electronic Drug Delivery Systems Market Competitive Landscape
  • 30.2. Electronic Drug Delivery Systems Market Company Profiles
    • 30.2.1. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Electronic Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care
  • 31.2. United Therapeutics Corporation
  • 31.3. F. Hoffmann-La Roche AG
  • 31.4. Elcam Medical
  • 31.5. Sanofi S.A.
  • 31.6. Cane SpA
  • 31.7. FindAir
  • 31.8. Johnson & Johnson Services Inc.
  • 31.9. Antares Pharma Inc
  • 31.10. Abbott Laboratories
  • 31.11. Adherium Ltd.
  • 31.12. H&T Presspart Manufacturing Ltd.
  • 31.13. HCmed Innovations Co. Ltd.
  • 31.14. Amiko Digital Health Limited
  • 31.15. CeQur Corporation

32. Global Electronic Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electronic Drug Delivery Systems Market

34. Recent Developments In The Electronic Drug Delivery Systems Market

35. Electronic Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Electronic Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Electronic Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Electronic Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer